Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. JYNT
JYNT logo

JYNT Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
8.560
Open
8.350
VWAP
8.46
Vol
32.14K
Mkt Cap
119.69M
Low
8.350
Amount
271.99K
EV/EBITDA(TTM)
116.02
Total Shares
14.11M
EV
95.13M
EV/OCF(TTM)
51.74
P/S(TTM)
2.32
The Joint Corp. is a franchisor and operator of chiropractic clinics that uses a private pay, non-insurance, cash-based model. The Company operates the Franchise Operations segment. The Company and its franchisees provide management services to affiliate professional chiropractic practices. The franchise system consists of approximately 811 clinics in operation. It offers a range of membership and wellness packages. It offers its patients the opportunity to visit its clinics without an appointment and receive prompt attention. Each patient's records are digitally updated for ready retrieval in its data storage system by its chiropractors in compliance with various applicable medical records security and privacy regulations.
Show More

Events Timeline

(ET)
2026-03-12
16:50:00
Company Reports Q4 Revenue of $15.17M, Beating Expectations
select
2025-11-06 (ET)
2025-11-06
17:01:00
Joint Corp. unveils new $12M stock buyback initiative
select
2025-11-06
17:00:15
Joint Corp. supports FY25 adjusted EBITDA forecast of $10.8M-$11.8M
select
2025-11-06
16:58:37
Joint Corp. announces Q3 earnings per share of 6 cents, surpassing consensus of 0 cents.
select
2025-11-05 (ET)
2025-11-05
07:43:30
Joint Corp. Board Approves $12 Million Increase in Share Buyback Program
select

News

seekingalpha
9.5
03-13seekingalpha
The Joint Corp. Q4 2025 Earnings Call Insights
  • Transformation Progress: CEO Sanjiv Razdan emphasized that the company is on track to complete its shift to a pure-play franchise model by the end of 2026, with only 48 corporate-owned clinics remaining from 135, which is expected to enhance operational efficiency and market competitiveness.
  • Financial Performance: CFO Scott Bowman reported that system-wide sales for 2025 were flat at $532 million, while adjusted EBITDA grew by 13.9% to $13 million, reflecting positive effects from cost optimization despite overall sales stagnation.
  • Marketing Adjustments: The company has shifted its marketing focus from broad wellness messaging to chiropractic care for pain relief, with a new national media program launched in November showing early signs of improvement in patient acquisition, although still below last year's levels.
  • Future Outlook: The company projects system-wide sales for 2026 to range between $519 million and $552 million, and despite challenges with new patient attrition, management remains optimistic about long-term growth potential, believing the U.S. market could support over 1,800 clinics.
NASDAQ.COM
2.0
03-12NASDAQ.COM
The Joint (JYNT) Q4 2025 Earnings Call Transcript
Globenewswire
5.0
01-05Globenewswire
The Joint Corp. Appoints Ron Stilwell as Senior VP of Operations and Patient Experience
  • Executive Appointment: The Joint Corp. has appointed Ron Stilwell as Senior Vice President of Operations and Patient Experience, effective immediately, following his role as President at FullSpeed Automotive, where he oversaw nearly 1,000 franchised units focusing on operational excellence and strategic growth.
  • Extensive Experience: With three decades of success in franchise operations, P&L management, and customer satisfaction, Stilwell previously helped Marco's Pizza achieve recognition as a top franchise brand known for rapid growth and operational excellence.
  • Strategic Goals: Reporting directly to CEO Sanjiv Razdan, Stilwell is expected to drive growth by enhancing patient experience and improving franchisee relations, thereby strengthening clinic economics and profitability.
  • Future Outlook: Stilwell expressed excitement about collaborating with management and franchisees to elevate patient experiences, with expectations to increase new patient acquisition, boost topline sales, and enhance profitability for both franchisees and the company.
Newsfilter
5.0
01-05Newsfilter
The Joint Corp. Appoints Ron Stilwell as SVP of Operations and Patient Experience
  • Executive Appointment: The Joint Corp. has appointed Ron Stilwell as Senior Vice President of Operations and Patient Experience, filling the role previously held by Eric Wyatt, and is expected to enhance patient experience and franchisee relations through his extensive expertise in franchise operations and customer satisfaction.
  • Industry Experience: During his tenure as President at FullSpeed Automotive, Stilwell successfully managed nearly 1,000 franchised units, driving strategic growth for flagship brands, demonstrating his capability in improving operational efficiency and profitability.
  • Strategic Goals: Stilwell expressed his commitment to enhancing patient experience and acquiring new patients, which is expected to drive sales growth for both the company and franchisees by improving service quality and overall profitability.
  • Market Leadership: As the largest chiropractic franchisor in the U.S. with over 950 locations and more than 14 million patient visits annually, The Joint's leadership position in the industry is further solidified with Stilwell's addition to the team.
NASDAQ.COM
4.5
2025-12-18NASDAQ.COM
Thursday's Underperforming Sectors: Oil & Gas Exploration, Rental, Leasing, and Royalty Stocks
  • Market Performance: Rental, leasing, and royalty shares are lagging behind the market, down approximately 0.9% overall.

  • Key Contributors: Research Frontiers and Joint are leading the decline, with shares down about 3.5% and 2.5%, respectively.

  • Sector Laggards: The oil and gas exploration and production sector is also noted as a laggard on the same day.

  • Author's Perspective: The views expressed in the article are those of the author and do not necessarily represent Nasdaq, Inc.

Globenewswire
8.5
2025-12-11Globenewswire
The Joint Corp. Sells 22 Clinics for $1.5 Million
  • Asset Sale: The Joint Corp. signed an Asset Purchase Agreement to sell 22 corporate-owned or managed clinics for $1.5 million, which is expected to enhance the company's financial flexibility and optimize asset allocation.
  • Management Service Agreements: Buyers will assume business operations via Management Service Agreements in mid-December until lease reassignments are completed, ensuring business continuity and minimizing operational disruption risks.
  • Existing Franchisee Expansion: Nine clinics will be purchased by an existing franchisee with over 13 years of experience, indicating franchisee confidence in the company's business model, which will help enhance brand image and market recognition.
  • Strategic Growth Plan: This transaction aligns with the company's strategy to reignite growth by attracting experienced operators, aiming to improve profitability at both clinic and company levels, thereby further solidifying its leadership position in the chiropractic care industry.
Wall Street analysts forecast JYNT stock price to rise
5 Analyst Rating
Wall Street analysts forecast JYNT stock price to rise
2 Buy
3 Hold
0 Sell
Moderate Buy
Current: 0.000
sliders
Low
9.00
Averages
11.33
High
14.00
Current: 0.000
sliders
Low
9.00
Averages
11.33
High
14.00
Roth Capital
Buy
downgrade
$14 -> $12
AI Analysis
2026-03-13
Reason
Roth Capital
Price Target
$14 -> $12
AI Analysis
2026-03-13
downgrade
Buy
Reason
Roth Capital lowered the firm's price target on Joint Corp. to $12 from $14 and keeps a Buy rating on the shares. The company's Q4 results exceeded estimates while its 2026 guidance largely mirrors the firm's model, the analyst tells investors in a research note. Roth adds, however, that the management's post-refranchising pro forma model is "underwhelming", even though it continues to see significant long-term upside.
B. Riley
B. Riley
Buy -> Neutral
downgrade
$18 -> $9
2025-11-07
Reason
B. Riley
B. Riley
Price Target
$18 -> $9
2025-11-07
downgrade
Buy -> Neutral
Reason
B. Riley downgraded Joint Corp. to Neutral from Buy with a price target of $9, down from $18. The company's Q3 comps were down 2.0%, reflecting continued softness in new patient acquisition, the analyst tells investors in a research note. The firm Joint's fiscal 2025 as "transitional," as the company tests initiatives and completes refranchising. It cites deteriorating trends for the downgrade.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for JYNT
Unlock Now

Valuation Metrics

The current forward P/E ratio for Joint Corp (JYNT.O) is 15.66, compared to its 5-year average forward P/E of 114.04. For a more detailed relative valuation and DCF analysis to assess Joint Corp's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
114.04
Current PE
15.66
Overvalued PE
214.29
Undervalued PE
13.79

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
27.59
Current EV/EBITDA
8.99
Overvalued EV/EBITDA
51.74
Undervalued EV/EBITDA
3.44

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
3.90
Current PS
2.29
Overvalued PS
7.89
Undervalued PS
-0.09

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

predict biggest winner ticker this year
Intellectia · 73 candidates
Market Cap: 100.00M - 30.00BBeta: HighRiskList Exchange: XNYS, XNAS, XASEOne Month Rise Prob: >= 55One Month Predict Return: >= 10.0%
Ticker
Name
Market Cap$
top bottom
JMIA logo
JMIA
Jumia Technologies AG
1.14B
LII logo
LII
Lennox International Inc
19.72B
DAVE logo
DAVE
Dave Inc
2.39B
LODE logo
LODE
Comstock Inc
196.99M
SMCI logo
SMCI
Super Micro Computer Inc
18.29B
FTCI logo
FTCI
FTC Solar Inc
141.78M

Whales Holding JYNT

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Joint Corp (JYNT) stock price today?

The current price of JYNT is 8.48 USD — it has increased 0.83

What is Joint Corp (JYNT)'s business?

The Joint Corp. is a franchisor and operator of chiropractic clinics that uses a private pay, non-insurance, cash-based model. The Company operates the Franchise Operations segment. The Company and its franchisees provide management services to affiliate professional chiropractic practices. The franchise system consists of approximately 811 clinics in operation. It offers a range of membership and wellness packages. It offers its patients the opportunity to visit its clinics without an appointment and receive prompt attention. Each patient's records are digitally updated for ready retrieval in its data storage system by its chiropractors in compliance with various applicable medical records security and privacy regulations.

What is the price predicton of JYNT Stock?

Wall Street analysts forecast JYNT stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for JYNT is11.33 USD with a low forecast of 9.00 USD and a high forecast of 14.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Joint Corp (JYNT)'s revenue for the last quarter?

Joint Corp revenue for the last quarter amounts to 15.17M USD, increased 3.08

What is Joint Corp (JYNT)'s earnings per share (EPS) for the last quarter?

Joint Corp. EPS for the last quarter amounts to 0.07 USD, decreased

How many employees does Joint Corp (JYNT). have?

Joint Corp (JYNT) has 202 emplpoyees as of March 27 2026.

What is Joint Corp (JYNT) market cap?

Today JYNT has the market capitalization of 119.69M USD.